iShares U.S. Pharmaceuticals ETF Rating $69.67 +0.57 (+0.82%) Closing price 08/15/2025 04:10 PM EasternExtended Trading$69.69 +0.02 (+0.04%) As of 08/15/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.66Holdings in IHE have an aggregate rating of Moderate Buy based on 245 analyst ratings issued in the past year covering 25 companies (96.0% of the portfolio).IHE Aggregate Price Target$69.67High Prediction$69.67Average Prediction$69.67Low Prediction$69.67Holdings in IHE have an aggregate price target of $69.67 and a range of $69.67 to $69.67 covering 25 companies (96.0% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings24.37%JNJJohnson & Johnson$176.76+1.2%4.8384 of 5 stars2.65$174.50 -1.3%20Positive News21.32%LLYEli Lilly and Company$701.51+2.5%4.9986 of 5 stars2.71$964.88 37.5%21Trending NewsAnalyst ForecastInsider TradeOptions VolumeAnalyst Revision4.93%RPRXRoyalty Pharma$36.35-0.4%4.9838 of 5 stars3.33$48.00 32.0%3Positive News4.46%MRKMerck & Co., Inc.$84.35+1.9%4.9972 of 5 stars2.35$107.44 27.4%20Positive NewsAnalyst Revision4.44%VTRSViatris$10.61-0.7%2.0503 of 5 stars1.80$10.40 -2.0%5Insider Trade4.34%PFEPfizer$25.16+0.2%4.9607 of 5 stars2.39$28.12 11.8%18Trending NewsAnalyst Revision4.01%ZTSZoetis$154.15+0.7%4.922 of 5 stars2.50$202.43 31.3%8Positive News3.99%BMYBristol Myers Squibb$48.45+1.3%4.7218 of 5 stars2.24$56.38 16.4%21Trending NewsAnalyst Revision3.52%JAZZJazz Pharmaceuticals$117.77+0.9%4.443 of 5 stars2.93$181.43 54.1%14Positive News3.38%ELANElanco Animal Health$17.97-0.2%2.9036 of 5 stars2.88$17.33 -3.5%8News Coverage3.22%CORTCorcept Therapeutics$71.75-0.3%4.7176 of 5 stars3.00$134.50 87.5%5News CoveragePositive NewsInsider Trade2.10%AXSMAxsome Therapeutics$109.21+0.4%4.6769 of 5 stars3.07$178.00 63.0%151.81%PRGOPerrigo$22.73-1.3%4.8525 of 5 stars2.40$33.00 45.2%5Analyst Upgrade1.80%PBHPrestige Consumer Healthcare$65.06+0.7%4.5518 of 5 stars2.50$93.33 43.5%6News Coverage1.26%LGNDLigand Pharmaceuticals$151.08-1.8%3.8589 of 5 stars3.00$157.00 3.9%6Short Interest ↓Gap Down1.25%OGNOrganon & Co.$9.43+0.4%4.6979 of 5 stars2.50$18.00 90.9%6Positive News0.98%SUPNSupernus Pharmaceuticals$42.69+1.2%2.3419 of 5 stars2.67$41.00 -4.0%3Positive News0.77%TARSTarsus Pharmaceuticals$54.21+0.1%1.81 of 5 stars3.00$66.67 23.0%7News CoverageInsider Trade0.76%OCULOcular Therapeutix$12.62-0.2%3.9904 of 5 stars3.00$17.20 36.3%50.65%HRMYHarmony Biosciences$36.87+1.0%4.5082 of 5 stars3.00$51.00 38.3%100.58%AMRXAmneal Pharmaceuticals$9.45+0.6%3.0694 of 5 stars3.00$11.60 22.8%5News CoverageInsider Trade0.54%ANIPANI Pharmaceuticals$87.47-2.8%3.2544 of 5 stars3.00$84.75 -3.1%9News CoverageEarnings ReportAnalyst UpgradeInsider Trade0.51%INVAInnoviva$20.92+0.2%4.4527 of 5 stars3.00$42.75 104.3%4News CoverageAnalyst UpgradeAnalyst Revision0.51%WVEWAVE Life Sciences$9.76+9.5%4.6888 of 5 stars2.93$20.27 107.7%150.50%PCRXPacira BioSciences$24.78-0.8%3.4715 of 5 stars2.83$30.83 24.4%6Positive News This page (NYSEARCA:IHE) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Debt Crisis Is Coming—Will You Be Ready?A full-blown "economic heart attack" is coming—and the markets aren't ready. The problem? Exploding U.S. de...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access